SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $8 to $10.
Fresh EU Tariffs Could Slow Down Tesla Chinese Rivals, But Warren Buffett-Backed BYD ‘Can Profitably Export Even At A 35% Tariff,’ Says Expert
The European Union has introduced new tariffs on electric vehicles manufactured in China, a move that could pose challenges for Chinese automakers. However, companies like BYD are expected to remain competitive.
